Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	23.4	50.19	55.14	97.47	79.51	164.89
Short-Term Investments	252.9	285.88	202.96	326.68	446.73	285.61
Cash & Short-Term Investments	276.3	336.08	258.11	424.15	526.24	450.5
Cash Growth	-13.74%	30.21%	-39.15%	-19.40%	16.81%	50.48%
Accounts Receivable	69.28	84.76	69.02	51.13	52.75	138.91
Other Current Assets	133.46	129.65	26.44	32.56	48.89	22.55
Total Current Assets	479.04	550.49	353.57	507.85	627.87	611.96
Net Property, Plant & Equipment	116.34	112.55	105.55	83.46	81.35	62.29
Other Intangible Assets	153.99	133.28	134.98	143.05	150.64	35.91
Goodwill	53.73	25.08	22.06	22.06	143.03	50.9
Long-Term Investments	328.29	369.27	570.35	444.01	339.03	507.01
Other Long-Term Assets	24.98	22.86	33.46	34.9	44.12	10.65
Total Assets	1,156	1,214	1,220	1,235	1,386	1,279
Accounts Payable	21.13	18.65	18.36	15.36	23.09	20.49
Accrued Expenses	34.9	34.06	24.28	30.74	24.98	18.48
Current Portion of Long-Term Debt	0.48	0.48	0.41	1.18	5.64	6.15
Unearned Revenue	33.63	31.78	29.84	25.57	14.09	34.38
Other Current Liabilities	-	-	-	0.16	20.3	25.82
Total Current Liabilities	90.13	84.97	72.9	73.02	88.11	105.31
Other Long-Term Liabilities	22.08	21.84	17.91	29.02	28.07	7.53
Total Long-Term Liabilities	22.08	21.84	17.91	29.02	28.07	7.53
Total Liabilities	112.22	106.81	90.81	102.04	116.18	112.84
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	540.14	574.52	543.13	501.72	486.59	501.91
Accumulated Other Comprehensive Income	4.54	7.51	-0.37	1.21	-20.9	-0.76
Retained Earnings	505.13	529.95	590.47	633.18	801	657.6
Total Common Shareholders' Equity	1,050	1,112	1,133	1,136	1,267	1,159
Minority Interest	-5.66	-5.27	-4.07	-2.82	3.19	7.13
Shareholders' Equity	1,044	1,107	1,129	1,133	1,270	1,166
Total Liabilities & Equity	1,156	1,214	1,220	1,235	1,386	1,279
Total Debt	0.48	0.48	0.41	1.18	5.64	6.15
Net Cash (Debt)	275.82	335.6	257.69	422.97	520.6	444.35
Net Cash Growth	-17.81%	30.23%	-39.07%	-18.75%	17.16%	48.43%
Net Cash Per Share	8.96	10.90	8.52	14.20	16.81	14.35
Book Value	1,050	1,112	1,133	1,136	1,267	1,159
Book Value Per Share	34.10	36.13	37.48	38.14	40.91	37.41
Tangible Book Value	842.09	953.63	976.2	970.99	973.02	1,072
Tangible Book Value Per Share	27.35	30.99	32.29	32.60	31.42	34.61

SEC Filings: 10-K · 10-Q